Viridian Therapeutics, Inc. (FRA:1S1)
27.68
+0.67 (2.48%)
Last updated: Dec 1, 2025, 8:06 AM CET
Viridian Therapeutics Employees
Viridian Therapeutics had 143 employees as of December 31, 2024. The number of employees increased by 49 or 52.13% compared to the previous year.
Employees
143
Change (1Y)
49
Growth (1Y)
52.13%
Revenue / Employee
€421,912
Profits / Employee
€1,462,130
Market Cap
2.58B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 143 | 49 | 52.13% |
| Dec 31, 2023 | 94 | 8 | 9.30% |
| Dec 31, 2022 | 86 | 36 | 72.00% |
| Dec 31, 2021 | 50 | 23 | 85.19% |
| Dec 31, 2020 | 27 | -19 | -41.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Viridian Therapeutics News
- 24 days ago - Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Wallstreet:Online
- 24 days ago - Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 25 days ago - VRDN: RBC Capital Raises Price Target for Viridian Therapeutics to $45.00 | VRDN Stock News - GuruFocus
- 25 days ago - Viridian Therapeutics Is Ready For An Eventful 2026 - Seeking Alpha
- 26 days ago - DRI Healthcare Reports Third Quarter 2025 Results - Benzinga
- 26 days ago - Viridian Therapeutics GAAP EPS of -$0.34 beats by $0.68, revenue of $70.57M - Seeking Alpha
- 26 days ago - Viridian (VRDN) Reports Robust Q3 Revenue Surpassing Expectations - GuruFocus
- 26 days ago - Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq